| Expression pattern: |
DN |
| Associated gene: |
- |
| Associated microRNA: |
miR-133a |
| Biological function: |
Protects LPS-induced HBEpCs from apoptosis and promotes cell viability; reduces inflammatory cytokine production in LPS-treated HBEpCs. |
| Molecular mechanism: |
Acts as a sponge/target of miR-133a; circFADS2 overexpression decreases miR-133a expression and reverses miR-133a-mediated effects on apoptosis/viability. |
| Biological pathway or process: |
apoptosis (inhibits); proliferation (promotes); inflammation (inhibits); ceRNA regulation (other) |
| Detected method: |
Q
|
| Validation methods: |
RT-qPCR; Clinical Sample Validation; Bioinformatics Analysis; Luciferase Reporter Assay; Transfection; MTT; Annexin V/PI Flow Cytometry; Western Blot; ELISA |
| Clinical significance: |
CircFADS2 is downregulated in plasma from sepsis patients compared with healthy controls. |
| Description: |
circFADS2 is downregulated in sepsis plasma and in LPS-treated human bronchial epithelial cells. Functionally, circFADS2 overexpression protects HBEpCs from LPS-induced apoptosis and loss of viability by sponging/downregulating miR-133a, supported by luciferase and gain/loss-of-function assays. |
| Confidence score: |
0.6521 |